Healthtech Startups
17,200 companies tagged Healthtech, with their investors and founders.
0 investors
MedZed provides in-person outreach and care management services for high-risk, hard-to-reach Medicaid and dual-eligible members, focusing on those who fall outside traditional health system care. The company serves health plans by conducting home visits and member calls to connect vulnerable populations with primary care and health management support.
0 investors
Mél Mont Medical develops a self-collection vaginal sampling device called Mía for cervical cancer screening that detects high-risk HPV DNA and active oncogenic E6/E7 mRNA overexpression without a speculum. The test is designed for women over 25 and provides actionable results to guide follow-up treatment decisions and prevent unnecessary procedures.
0 investors
0 investors
Memgen develops viral, cell-based, and vaccine adjuvant immunotherapies built on its proprietary CD40 ligand technology for treating cancer. Its lead candidate, MEM-288, combines the CD40 ligand with interferon beta and is in phase 1 clinical trials for advanced non-small cell lung cancer.
0 investors
A surgical center operating under SCA Health that provides outpatient surgery and procedures for patients. The center emphasizes clinical quality and service excellence in ambulatory surgery and gastroenterology procedures.
0 investors
0 investors
0 investors
0 investors
0 investors
Mental Health Center of America (MHCA) operates integrated, multi-disciplinary mental health clinics offering psychiatry, counseling, psychological testing, intensive outpatient programs, TMS, and neurofeedback coordinated by one care team sharing a single chart. It serves adults and children in Arizona through in-person clinics in Mesa and Glendale and telepsychiatry across the state.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing therapeutics for metabolic diseases linked to age-related mitochondrial dysfunction, particularly insulin resistance and type 2 diabetes.
0 investors
0 investors
0 investors
0 investors